Scientific article
Open access

Pathophysiology of NASH in endocrine diseases

Published inEndocrine Connections, vol. 10, no. 2, p. R52-R65
Publication date2021

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the industrialized world. NAFLD encompasses a whole spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. The latter can lead to hepatocellular carcinoma. Furthermore, NASH is the most rapidly increasing indication for liver transplantation in western countries and therefore represents a global health issue. The pathophysiology of NASH is complex and includes multiple parallel hits. NASH is notably characterized by steatosis as well as evidence of hepatocyte injury and inflammation, with or without fibrosis. NASH is frequently associated with type 2 diabetes and conditions associated with insulin resistance. Moreover, NASH may also be found in many other endocrine diseases such as polycystic ovary syndrome, hypothyroidism, male hypogonadism, growth hormone deficiency or glucocorticoid excess, for example. In this review, we will discuss the pathophysiology of NASH associated with different endocrinopathies.

  • NASH
  • Endocrine diseases
  • Insulin resistance
Citation (ISO format)
GARIANI, Karim, JORNAYVAZ, François. Pathophysiology of NASH in endocrine diseases. In: Endocrine Connections, 2021, vol. 10, n° 2, p. R52–R65. doi: 10.1530/EC-20-0490
Main files (1)
Article (Published version)
ISSN of the journal2049-3614

Technical informations

Creation03/23/2021 10:29:00 AM
First validation03/23/2021 10:29:00 AM
Update time03/16/2023 1:21:15 AM
Status update03/16/2023 1:21:14 AM
Last indexation02/12/2024 1:30:23 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack